Projects & Resources

• Contraceptive Technology Innovation (CTI) Initiative

  The goal of the Contraceptive Technology Innovation (CTI) Initiative is to develop new and strategically important contraceptives, through a strong focus on global partnerships, that ensures wide access to quality, affordable and acceptable products for those most in need.

• FEM-PrEP

  The FEM-PrEP clinical trial was designed to assess whether a daily dose of the antiretroviral Truvada® is safe and effective at preventing HIV infection among women at high risk of HIV exposure.

• Pre-exposure Prophylaxis for HIV Infection Among African Women

  The primary results of a trial of once-daily oral Truvada for pre-exposure prophylaxis for HIV infection among women in Africa (FEM-PrEP) are presented in an article published in The New England Journal of Medicine.